Acquisition of a stake in Provepharm by Archimed and Téthys

In March 2018, Archimed and Téthys acquired a minority stake in Provepharm alongside its founders and the historical shareholders.

Bucéphale Finance acted as exclusive financial advisor to its founders and the sellers in this transaction.

Back >

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.